Schrödinger, Inc. (NASDAQ:SDGR) Stock Holdings Increased by Zurcher Kantonalbank Zurich Cantonalbank

Zurcher Kantonalbank Zurich Cantonalbank boosted its stake in shares of Schrödinger, Inc. (NASDAQ:SDGR) by 18.8% during the second quarter, according to its most recent disclosure with the SEC. The institutional investor owned 19,581 shares of the company’s stock after purchasing an additional 3,103 shares during the period. Zurcher Kantonalbank Zurich Cantonalbank’s holdings in Schrödinger were worth $379,000 at the end of the most recent reporting period.

Several other large investors have also recently added to or reduced their stakes in the stock. Russell Investments Group Ltd. raised its holdings in shares of Schrödinger by 22.7% during the first quarter. Russell Investments Group Ltd. now owns 218,564 shares of the company’s stock worth $5,901,000 after acquiring an additional 40,434 shares in the last quarter. Vanguard Group Inc. lifted its holdings in shares of Schrödinger by 1.2% during the 4th quarter. Vanguard Group Inc. now owns 6,776,631 shares of the company’s stock valued at $242,603,000 after buying an additional 77,830 shares during the last quarter. Parkman Healthcare Partners LLC grew its stake in shares of Schrödinger by 9.9% in the 4th quarter. Parkman Healthcare Partners LLC now owns 405,232 shares of the company’s stock valued at $14,507,000 after buying an additional 36,578 shares in the last quarter. PNC Financial Services Group Inc. raised its position in Schrödinger by 186.7% during the fourth quarter. PNC Financial Services Group Inc. now owns 2,127 shares of the company’s stock valued at $76,000 after acquiring an additional 1,385 shares in the last quarter. Finally, Iron Triangle Partners LP acquired a new stake in Schrödinger in the fourth quarter valued at approximately $16,775,000. Institutional investors and hedge funds own 79.05% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have recently commented on SDGR shares. KeyCorp dropped their price target on shares of Schrödinger from $30.00 to $25.00 and set an “overweight” rating on the stock in a research note on Thursday, July 11th. Leerink Partners started coverage on Schrödinger in a report on Tuesday, July 2nd. They set an “outperform” rating and a $29.00 target price on the stock. Leerink Partnrs upgraded Schrödinger to a “strong-buy” rating in a research note on Tuesday, July 2nd. Finally, Morgan Stanley reduced their target price on Schrödinger from $43.00 to $30.00 and set an “equal weight” rating for the company in a report on Wednesday, August 21st. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has issued a strong buy rating to the stock. According to MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and a consensus target price of $33.44.

Schrödinger Stock Down 0.1 %

SDGR opened at $20.50 on Friday. The stock’s 50 day moving average price is $20.82 and its two-hundred day moving average price is $23.07. The firm has a market capitalization of $1.49 billion, a P/E ratio of -10.90 and a beta of 1.51. Schrödinger, Inc. has a 12-month low of $18.02 and a 12-month high of $38.00.

Schrödinger Profile

Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.